Shares of Novo Nordisk and Eli Lilly dropped on Wednesday following the release of promising early-stage trial data from Roche's new obesity drug candidate. Roche announced that its experimental once-daily pill showed an average weight loss of 6.1% over four weeks.
#roche #obesitypill #wion
About Channel:
WION The World is One News examines global issues with in-depth analysis. We provide much more than the news of the day. Our aim is to empower people to explore their world. With our Global headquarters in New Delhi, we bring you news on the hour, by the hour. We deliver information that is not biased. We are journalists who are neutral to the core and non-partisan when it comes to world politics. People are tired of biased reportage and we stand for a globalized united world. So for us, the World is truly One.
Please keep discussions on this channel clean and respectful and refrain from using racist or sexist slurs and personal insults.
Subscribe to our channel at [ Ссылка ]
Check out our website: [ Ссылка ]
Join our WhatsApp Channel: [ Ссылка ]
Connect with us on our social media handles:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Follow us on Google News for the latest updates
Zee News:- [ Ссылка ]
Zee Business:- [ Ссылка ]
DNA India:- [ Ссылка ]
WION: [ Ссылка ]
Zee News Apps: [ Ссылка ]
